Tech Company Financing Transactions

NovaVision Funding Round

Chicago Growth Partners, Crossbow Ventures and Johnson & Johnson Development Corporation invested in a $20 million Series C capital raise for NovaVision. The funding round was announced on 1/10/2007.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series C
Proceeds Purpose
The financing will enable the company to continue expanding the national availability of NovaVision VRTTM Vision Restoration TherapyTM (VRT), the first and only FDA-cleared, patented, non-invasive medical device that can enhance vision in people who have been left partially blind due to stroke or brain trauma.

Company Information

Company Status
Private & Independent
Medical Devices & Instruments
Mailing Address
951 Broken Sound Pkwy. 320
Boca Raton, FL 33487
Email Address
The company made great strides increasing the commercial availability of VRT in 2004, and I look forward to the day when it becomes as common as speech, physical and occupational therapies
NovaVision LinkedIn Company Profile
Social Media
NovaVision Company Twitter Account
Company News
NovaVision News
NovaVision on Facebook
NovaVision on YouTube

Management Team

Email & Social
Chief Executive Officer
Rudy Mazzocchi
  Rudy Mazzocchi LinkedIn Profile  Rudy Mazzocchi Twitter Account  Rudy Mazzocchi News  Rudy Mazzocchi on Facebook



Browse more venture capital transactions:

Prev: 1/9/2007: Wetpaint venture capital transaction
Next: 1/10/2007: Discretix venture capital transaction


Share this article


About Our Venture Capital Transactions Database

We do our best to record funding rounds that are announced publicly. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary